DSpace Repository

LB62 Ofatumumab vs Teriflunomide in Relapsing Multiple Sclerosis: Analysis of No Evidence of Disease Activity (NEDA-3) from ASCLEPIOS I and II Trials

LB62 Ofatumumab vs Teriflunomide in Relapsing Multiple Sclerosis: Analysis of No Evidence of Disease Activity (NEDA-3) from ASCLEPIOS I and II Trials

Hauser, Stephen L.; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Willi, Roman; Li, Bingbing; Häring, Dieter A.; Ramnathan, Krishnan; Merschhemke, Martin; Kappos, Ludwig
URI: https://repositorio.fleni.org.ar/xmlui/handle/123456789/574
https://onlinelibrary.wiley.com/doi/10.1111/ene.14363
Date: 2020-05-27

Show full item record

Files in this item

Thumbnail
Name: Hauser_2020_Ofatu ...
Size: 202.6Kb
Format: PDF
View/Open

This item appears in the following Collection(s)

info:eu-repo/semantics/openAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess

Search DSpace


Browse

My Account

Statistics